{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,24]],"date-time":"2026-08-24T18:42:54Z","timestamp":1787596974744,"version":"build-2736575974"},"reference-count":45,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,12,1]],"date-time":"2020-12-01T00:00:00Z","timestamp":1606780800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,12,1]],"date-time":"2020-12-01T00:00:00Z","timestamp":1606780800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2020,10,26]],"date-time":"2020-10-26T00:00:00Z","timestamp":1603670400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001303","name":"CEM","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001303","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100013722","name":"OBC","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100013722","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","thebreastonline.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Breast"],"published-print":{"date-parts":[[2020,12]]},"DOI":"10.1016\/j.breast.2020.10.012","type":"journal-article","created":{"date-parts":[[2020,10,27]],"date-time":"2020-10-27T17:02:16Z","timestamp":1603818136000},"page":"211-215","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":62,"special_numbering":"C","title":["Occult breast cancer: Where are we at?"],"prefix":"10.1016","volume":"54","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4940-4674","authenticated-orcid":false,"given":"Adam","family":"Ofri","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katrina","family":"Moore","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"4","key":"10.1016\/j.breast.2020.10.012_bib1","first-page":"373","article-title":"Unexplained lymphadenopathy in family practice. An evaluation of the probability of malignant causes and the effectiveness of physicians\u2019 workup","volume":"27","author":"Fijten","year":"1988","journal-title":"J\u00a0Fam Pract"},{"issue":"6","key":"10.1016\/j.breast.2020.10.012_bib2","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1177\/030089169608200617","article-title":"Differential diagnosis of axillary masses","volume":"82","author":"de Andrade","year":"1996","journal-title":"Tumori"},{"issue":"4","key":"10.1016\/j.breast.2020.10.012_bib3","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1159\/000326567","article-title":"Diagnostic value of needle aspiration cytology in the assessment of palpable axillary lymph nodes. A study of 336 cases","volume":"47","author":"Gupta","year":"2003","journal-title":"Acta Cytol"},{"issue":"6","key":"10.1016\/j.breast.2020.10.012_bib4","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1007\/s00268-004-7290-y","article-title":"Retrospective study of women presenting with axillary metastases from occult breast carcinoma","volume":"28","author":"Blanchard","year":"2004","journal-title":"World J Surg"},{"issue":"1","key":"10.1016\/j.breast.2020.10.012_bib5","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1097\/00000658-190707000-00001","article-title":"The results of radical operations for the cure of carcinoma of the breast","volume":"46","author":"Halsted","year":"1907","journal-title":"Ann Surg"},{"issue":"1","key":"10.1016\/j.breast.2020.10.012_bib6","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/S0360-3016(99)00542-8","article-title":"Occult breast carcinoma presenting as axillary metastases","volume":"47","author":"Foroudi","year":"2000","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"17","key":"10.1016\/j.breast.2020.10.012_bib7","doi-asserted-by":"crossref","first-page":"4000","DOI":"10.1002\/cncr.25197","article-title":"Population-based analysis of occult primary breast cancer with axillary lymph node metastasis","volume":"116","author":"Walker","year":"2010","journal-title":"Cancer"},{"issue":"1","key":"10.1016\/j.breast.2020.10.012_bib8","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/0002-9610(86)90135-2","article-title":"Occult primary adenocarcinoma with axillary metastases","volume":"152","author":"Kemeny","year":"1986","journal-title":"Am J Surg"},{"issue":"10","key":"10.1016\/j.breast.2020.10.012_bib9","doi-asserted-by":"crossref","first-page":"2907","DOI":"10.1245\/s10434-017-5928-x","article-title":"Factors influencing management and outcome in patients with occult breast cancer with axillary lymph node involvement: analysis of the national cancer database","volume":"24","author":"Hessler","year":"2017","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.breast.2020.10.012_bib10","author":"Network"},{"key":"10.1016\/j.breast.2020.10.012_bib11","author":"Radiology"},{"issue":"2","key":"10.1016\/j.breast.2020.10.012_bib12","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1016\/j.ejso.2009.09.007","article-title":"Breast MRI in clinically and mammographically occult breast cancer presenting with an axillary metastasis: a systematic review","volume":"36","author":"de Bresser","year":"2010","journal-title":"Eur J Surg Oncol"},{"issue":"6","key":"10.1016\/j.breast.2020.10.012_bib13","doi-asserted-by":"crossref","first-page":"W611","DOI":"10.2214\/AJR.11.7463","article-title":"Comparison of 3- and 1.5-T dynamic breast MRI for visualization of spiculated masses previously identified using mammography","volume":"198","author":"Uematsu","year":"2012","journal-title":"AJR Am J Roentgenol"},{"issue":"1","key":"10.1016\/j.breast.2020.10.012_bib14","first-page":"65","article-title":"Breast MRI: intraindividual comparative study at 1.5 and 3.0T; initial experience","volume":"17","author":"Djilas-Ivanovic","year":"2012","journal-title":"J\u00a0BUON"},{"issue":"8","key":"10.1016\/j.breast.2020.10.012_bib15","doi-asserted-by":"crossref","first-page":"285","DOI":"10.4329\/wjr.v5.i8.285","article-title":"3.0 Tesla vs 1.5 Tesla breast magnetic resonance imaging in newly diagnosed breast cancer patients","volume":"5","author":"Butler","year":"2013","journal-title":"World J Radiol"},{"key":"10.1016\/j.breast.2020.10.012_bib16","first-page":"1358","article-title":"Comparison between breast MRI and contrast-enhanced spectral mammography","volume":"21","author":"Luczynska","year":"2015","journal-title":"Med Sci Mon Int Med J Exp Clin Res"},{"issue":"2","key":"10.1016\/j.breast.2020.10.012_bib17","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1016\/j.mric.2017.12.005","article-title":"Comparison of contrast-enhanced mammography and contrast-enhanced breast MR imaging","volume":"26","author":"Lewin","year":"2018","journal-title":"Magn Reson Imag Clin N Am"},{"key":"10.1016\/j.breast.2020.10.012_bib18","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.ejrad.2017.10.001","article-title":"Comparison of screening CEDM and MRI for women at increased risk for breast cancer: a pilot study","volume":"97","author":"Jochelson","year":"2017","journal-title":"Eur J Radiol"},{"issue":"3","key":"10.1016\/j.breast.2020.10.012_bib19","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1148\/radiol.2019182789","article-title":"Diffusion-weighted MRI for unenhanced breast cancer screening","volume":"293","author":"Amornsiripanitch","year":"2019","journal-title":"Radiology"},{"issue":"8","key":"10.1016\/j.breast.2020.10.012_bib20","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1097\/RLU.0000000000000503","article-title":"FDG PET\/CT reveals the primary tumor in a patient with occult breast carcinoma undetected by other modalities","volume":"39","author":"Liu","year":"2014","journal-title":"Clin Nucl Med"},{"issue":"2","key":"10.1016\/j.breast.2020.10.012_bib21","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1007\/s00259-013-2553-1","article-title":"Breast cancer detection using high-resolution breast PET compared to whole-body PET or PET\/CT","volume":"41","author":"Kalinyak","year":"2014","journal-title":"Eur J Nucl Med Mol Imag"},{"issue":"1","key":"10.1016\/j.breast.2020.10.012_bib22","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1148\/radiol.10100454","article-title":"Breast cancer: comparative effectiveness of positron emission mammography and MR imaging in presurgical planning for the ipsilateral breast","volume":"258","author":"Berg","year":"2011","journal-title":"Radiology"},{"issue":"12","key":"10.1016\/j.breast.2020.10.012_bib23","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1245\/ASO.2005.03.520","article-title":"Utility of breast magnetic resonance imaging in patients with occult primary breast cancer","volume":"12","author":"Buchanan","year":"2005","journal-title":"Ann Surg Oncol"},{"issue":"1","key":"10.1016\/j.breast.2020.10.012_bib24","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1111\/j.1524-4741.2009.00848.x","article-title":"Clinical benefits of mastectomy on treatment of occult breast carcinoma presenting axillary metastases","volume":"16","author":"Wang","year":"2010","journal-title":"Breast J"},{"key":"10.1016\/j.breast.2020.10.012_bib25","first-page":"4381","article-title":"Clinicopathological characteristics and treatment outcomes of occult breast cancer: a SEER population-based study","volume":"10","author":"Ge","year":"2018","journal-title":"Canc Manag Res"},{"issue":"3","key":"10.1016\/j.breast.2020.10.012_bib26","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1002\/jso.23644","article-title":"Treatment and survival of patients with occult breast cancer with axillary lymph node metastasis: a nationwide retrospective study","volume":"110","author":"Sohn","year":"2014","journal-title":"J\u00a0Surg Oncol"},{"issue":"6","key":"10.1016\/j.breast.2020.10.012_bib27","doi-asserted-by":"crossref","first-page":"1838","DOI":"10.1245\/s10434-016-5104-8","article-title":"Optimal surgical management for occult breast carcinoma: a meta-analysis","volume":"23","author":"Macedo","year":"2016","journal-title":"Ann Surg Oncol"},{"issue":"1","key":"10.1016\/j.breast.2020.10.012_bib28","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1245\/s10434-014-3991-0","article-title":"Breast conservation in the setting of contemporary multimodality treatment provides excellent outcomes for patients with occult primary breast cancer","volume":"22","author":"Rueth","year":"2015","journal-title":"Ann Surg Oncol"},{"issue":"4","key":"10.1016\/j.breast.2020.10.012_bib29","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1016\/0167-8140(89)90077-7","article-title":"Presentation of axillary lymphadenopathy without detectable breast primary (T0 N1b breast cancer): experience at Institut Curie","volume":"15","author":"Campana","year":"1989","journal-title":"Radiother Oncol"},{"issue":"7","key":"10.1016\/j.breast.2020.10.012_bib30","doi-asserted-by":"crossref","first-page":"1461","DOI":"10.1002\/1097-0142(19901001)66:7<1461::AID-CNCR2820660704>3.0.CO;2-Z","article-title":"Treatment of patients with isolated axillary nodal metastases from an occult primary carcinoma consistent with breast origin","volume":"66","author":"Ellerbroek","year":"1990","journal-title":"Cancer"},{"issue":"5","key":"10.1016\/j.breast.2020.10.012_bib31","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1054\/brst.2002.0455","article-title":"Occult primary breast carcinoma presenting as axillary lymphadenopathy","volume":"11","author":"Shannon","year":"2002","journal-title":"Breast"},{"issue":"2","key":"10.1016\/j.breast.2020.10.012_bib32","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.clon.2010.10.001","article-title":"Breast radiotherapy for occult breast cancer with axillary nodal metastases--does it reduce the local recurrence rate and increase overall survival?","volume":"23","author":"Masinghe","year":"2011","journal-title":"Clin Oncol"},{"key":"10.1016\/j.breast.2020.10.012_bib33","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.breast.2019.10.017","article-title":"Outcome of breast-conserving treatment for axillary lymph node metastasis from occult breast cancer with negative breast MRI","volume":"49","author":"Kim","year":"2019","journal-title":"Breast"},{"issue":"1","key":"10.1016\/j.breast.2020.10.012_bib34","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s10549-009-0554-3","article-title":"Axillary nodal metastases from carcinoma of unknown primary (CUPAx): a systematic review of published evidence","volume":"119","author":"Pentheroudakis","year":"2010","journal-title":"Breast Canc Res Treat"},{"issue":"18","key":"10.1016\/j.breast.2020.10.012_bib35","first-page":"3849","article-title":"Comparable survival between additional radiotherapy and local surgery in occult breast cancer after axillary lymph node dissection: a population-based analysis","volume":"8","author":"Wu","year":"2017","journal-title":"J\u00a0Canc"},{"issue":"9804","key":"10.1016\/j.breast.2020.10.012_bib36","doi-asserted-by":"crossref","first-page":"1707","DOI":"10.1016\/S0140-6736(11)61629-2","article-title":"Effect of radiotherapy after breast-conserving surgery on 10-year recurrence and 15-year breast cancer death: meta-analysis of individual patient data for 10,801 women in 17 randomised trials","volume":"378","year":"2011","journal-title":"Lancet"},{"issue":"1","key":"10.1016\/j.breast.2020.10.012_bib37","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.radonc.2017.03.001","article-title":"The effect of post-mastectomy radiation in women with one to three positive nodes enrolled on the control arm of BCIRG-005 at ten year follow-up","volume":"123","author":"Tam","year":"2017","journal-title":"Radiother Oncol"},{"issue":"12","key":"10.1016\/j.breast.2020.10.012_bib38","article-title":"Post-mastectomy radiotherapy for breast cancer patients with t1-t2 and 1-3 positive lymph nodes: a meta-analysis","volume":"8","author":"Li","year":"2013","journal-title":"PloS One"},{"issue":"11","key":"10.1016\/j.breast.2020.10.012_bib39","doi-asserted-by":"crossref","first-page":"3141","DOI":"10.1245\/s10434-017-5965-5","article-title":"Oncologic outcomes after treatment for MRI occult breast cancer (pT0N+)","volume":"24","author":"McCartan","year":"2017","journal-title":"Ann Surg Oncol"},{"issue":"1","key":"10.1016\/j.breast.2020.10.012_bib40","doi-asserted-by":"crossref","first-page":"13123","DOI":"10.1038\/s41598-019-49644-6","article-title":"21-Gene recurrence score and adjuvant chemotherapy decision for breast cancer patients with positive lymph nodes","volume":"9","author":"Tong","year":"2019","journal-title":"Sci Rep"},{"issue":"7","key":"10.1016\/j.breast.2020.10.012_bib41","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1016\/S1470-2045(13)70166-9","article-title":"Sentinel-lymph-node biopsy in patients with breast cancer before and after neoadjuvant chemotherapy (SENTINA): a prospective, multicentre cohort study","volume":"14","author":"Kuehn","year":"2013","journal-title":"Lancet Oncol"},{"issue":"14","key":"10.1016\/j.breast.2020.10.012_bib42","doi-asserted-by":"crossref","first-page":"1455","DOI":"10.1001\/jama.2013.278932","article-title":"Sentinel lymph node surgery after neoadjuvant chemotherapy in patients with node-positive breast cancer: the ACOSOG Z1071 (Alliance) clinical trial","volume":"310","author":"Boughey","year":"2013","journal-title":"J\u00a0Am Med Assoc"},{"issue":"10","key":"10.1016\/j.breast.2020.10.012_bib43","doi-asserted-by":"crossref","first-page":"3030","DOI":"10.1245\/s10434-018-6575-6","article-title":"Improved false-negative rates with intraoperative identification of clipped nodes in patients undergoing sentinel lymph node biopsy after neoadjuvant chemotherapy","volume":"25","author":"Cabioglu","year":"2018","journal-title":"Ann Surg Oncol"},{"issue":"4","key":"10.1016\/j.breast.2020.10.012_bib44","doi-asserted-by":"crossref","first-page":"802","DOI":"10.1097\/SLA.0000000000001375","article-title":"Identification and resection of clipped node decreases the false-negative rate of sentinel lymph node surgery in patients presenting with node-positive breast cancer (T0-T4, N1-N2) who receive neoadjuvant chemotherapy: results from ACOSOG Z1071 (alliance)","volume":"263","author":"Boughey","year":"2016","journal-title":"Ann Surg"},{"issue":"10","key":"10.1016\/j.breast.2020.10.012_bib45","doi-asserted-by":"crossref","first-page":"1072","DOI":"10.1200\/JCO.2015.64.0094","article-title":"Improved axillary evaluation following neoadjuvant therapy for patients with node-positive breast cancer using selective evaluation of clipped nodes: implementation of targeted axillary dissection","volume":"34","author":"Caudle","year":"2016","journal-title":"J\u00a0Clin Oncol"}],"container-title":["The Breast"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0960977620302034?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0960977620302034?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,18]],"date-time":"2025-10-18T08:43:18Z","timestamp":1760776998000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0960977620302034"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,12]]},"references-count":45,"alternative-id":["S0960977620302034"],"URL":"https:\/\/doi.org\/10.1016\/j.breast.2020.10.012","relation":{},"ISSN":["0960-9776"],"issn-type":[{"value":"0960-9776","type":"print"}],"subject":[],"published":{"date-parts":[[2020,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Occult breast cancer: Where are we at?","name":"articletitle","label":"Article Title"},{"value":"The Breast","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.breast.2020.10.012","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}